Novavax secures a licensing deal worth up to $1.2 billion with Sanofi for its COVID-19 vaccine, entailing a stake in Novavax valued
Novavax secures a licensing deal worth up to $1.2 billion with Sanofi for its COVID-19 vaccine, entailing a stake in Novavax valued